Official Malaysian Government Website
Newsroom
868 items
Announcements, product safety communications and regulatory updates.
Date: 14 April 2014 Description: A Direct Healthcare Professional Communication (DHPC) has been approved by NPCB to inform healthcare professionals of dose-dependent QT interval prolongation –…
Date: 17 April 2014 Description: A Direct Healthcare Professional Communication (DHPC) has been approved by NPCB to inform healthcare professionals regarding the contraindication of Erbitux®…
Date: 18 April 2014 Description: A Direct Healthcare Professional Communication (DHPC) has been approved by NPCB to inform healthcare professionals of serious skin reactions, namely Stevens-Johnson…
Date: 25 April 2014 Description: A Direct Healthcare Professional Communication (DHPC) has been approved by NPCB to inform healthcare professionals of serious skin reactions, namely Stevens-Johnson…
Date: 14 May 2014 Description: NPCB would like to inform all healthcare professionals that a Safety Update Report [Ref: (1) dlm. BPFK/PASCA/FV/16] has been issued as above. Following a review of the…
Date: 21 May 2014 Description: Healthcare professionals should take note that very rare cases of severe adverse cutaneous reactions such as toxic epidermal necrolysis (TEN) and Stevens-Johnson…
Date: 09 June 2014 Description: The NPCB would like to alert healthcare professionals on the risk of intraoperative floppy iris syndrome (IFIS) during and after cataract surgery in patients treated…
Date: 07 July 2014 Description: A Direct Healthcare Professional Communication (DHPC) has been approved by NPCB to inform healthcare professionals of serious skin reactions, namely Stevens-Johnson…
Date: 07 July 2014 Description: A Direct Healthcare Professional Communication (DHPC) has been approved by NPCB to inform healthcare professionals of the new antibody persistence data for Mencevax…
Date: 08 July 2014 Description: The NPCB has approved a Direct Healthcare Professional Communication (DHPC) on a new warning of priapism associated with Ritalin and Ritalin LA®. Prolonged and painful…
Date: 06 August 2014 Description: The NPCB would like to alert healthcare professionals that cases of capillary leak syndrome (CLS) have been reported in recipients of filgrastim including patients…
Date: 13 August 2014 Description: This issue was highlighted in a previous NPCB Safety Alert issued on 27 January 2014. Following completion of NPCB’s benefit-risk profile review related to…
Date: 16 August 2014 Description: The NPCB would like to alert healthcare professionals that cases of capillary leak syndrome (CLS) have been reported in recipients of filgrastim including patients…
Date: 07 October 2014 Description: A Direct Healthcare Professional Communication (DHPC) has been approved by NPCB to inform healthcare professionals of new safety information from a clinical trial…
Date: 17 October 2014 Description: The NPCB has approved a Direct Healthcare Professional Communication (DHPC) to alert healthcare professionals that visual field defects have been reported in…
Date: 17 December 2014 Description: The NPCB would like to alert healthcare professionals that cases of serious skin reactions (Stevens Johnson Syndrome and acute generalised exanthematous…
Date: 12 February 2015 Description: A Direct Healthcare Professional Communication (DHPC) has been approved by NPCB to inform healthcare professionals of the risk of severe diarrhoea and…
Date: 23 March 2015 Description: The NPCB has approved a Direct Healthcare Professional Communication (DHPC) on new recommendations to reduce the risk of SSH and ONJ associated with Xgeva®. Calcium…
